ERCC1 expression in aseptic loosening after total hip replacement

Area of Science:

• Orthopedic Surgery
• Cellular Biology
• Biomaterials Science

Background:

• Particle-induced osteolysis is a primary cause of aseptic loosening in total joint replacements.
• Assessing macrophage DNA damage repair capacity is crucial for understanding aseptic loosening.
• ERCC1 (excision repair cross-complementation group 1) is a key DNA repair protein.

Purpose of the Study:

• To evaluate the DNA damage repair capacity of macrophages in patients with aseptic hip loosening by measuring ERCC1 expression.
• To determine if DNA repair mechanisms correlate with joint implant survival.
• To differentiate early (within 10 years) versus late (after 10 years) aseptic loosening based on ERCC1 levels.

Main Methods:

• Immunohistochemical analysis of ERCC1 expression in hip replacement capsules and interface membranes.
• Semi-quantitative H-score calculation (staining intensity x proportion of positive macrophages).
• Comparison of ERCC1 H-scores between early and late aseptic loosening patient groups.

Main Results:

• Lower ERCC1 expression (mean H-score 0.57) was observed in patients with early aseptic loosening compared to those with late loosening (mean H-score 2.24).
• An ERCC1 H-score cutoff of 1 demonstrated 100% sensitivity and specificity for identifying early aseptic loosening (less than 10 years).

Conclusions:

• Reduced ERCC1 levels in macrophages are associated with early aseptic loosening after total joint replacement.
• ERCC1 expression serves as a potential biomarker for distinguishing early from late aseptic loosening.
• Further research may link ERCC1 levels to joint implant survival rates.